Denali Therapeutics Inc.
Singkat

DNLI: Higher price rejection after gap up

71
Higher price rejection after spike up and gap up.
May try to fill the gap.
If confirmed:
PT1 = 30,01
PT2 = 23,90 (for gap fill)

Penafian

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.